000285381 001__ 285381
000285381 005__ 20240303005636.0
000285381 0247_ $$2doi$$a10.1007/s00520-023-08124-4
000285381 0247_ $$2pmid$$apmid:37955790
000285381 0247_ $$2ISSN$$a0941-4355
000285381 0247_ $$2ISSN$$a1433-7339
000285381 0247_ $$2altmetric$$aaltmetric:156821493
000285381 037__ $$aDKFZ-2023-02350
000285381 041__ $$aEnglish
000285381 082__ $$a610
000285381 1001_ $$00000-0003-4892-4061$$aSweegers, Maike G$$b0
000285381 245__ $$aPerspectives of patients with metastatic breast cancer on physical exercise programs: results from a survey in five European countries.
000285381 260__ $$aNew York,NY$$bSpringer$$c2023
000285381 3367_ $$2DRIVER$$aarticle
000285381 3367_ $$2DataCite$$aOutput Types/Journal article
000285381 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1699971714_1527
000285381 3367_ $$2BibTeX$$aARTICLE
000285381 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000285381 3367_ $$00$$2EndNote$$aJournal Article
000285381 520__ $$aTo successfully implement exercise programs for patients with metastatic breast cancer (MBC), services and patient education should consider patients' knowledge, preferences, values, and goals. Hence, gaining insight into their perspectives on exercise and exercise programming is important.In this cross-sectional survey, we recruited patients with MBC from the Netherlands, Germany, Poland, Spain, and Sweden. We collected data on patients' knowledge and skills about exercise and outcome expectations. We identified barriers to and facilitators of participation in exercise programs, and patients' preferences for program content and modes of exercise delivery.A total of 420 patients participated in the survey. Respondents were, on average, 56.5 years old (SD 10.8) and 70% had bone metastases. Sixty-eight percent reported sufficient skills to engage in aerobic exercise, but only 35% did so for resistance exercise. Respondents expected exercise to have multiple physical benefits, but a few patients expected exercise to worsen their pain (5%). Not having access to an exercise program for cancer patients (27%), feeling too tired (23%), and/or weak (23%) were the most often reported barriers. Facilitators for exercising regularly were previous positive physical (72%) and emotional (68%) experiences with exercising, and receiving personalized advice from a physiotherapist or sport/fitness instructor (62%). Patients were most interested in walking and preferred exercising at a public gym, although there were differences by country. Fifty-seven percent did not know whether their insurance company reimburses exercise programs and only 9% would be willing to pay more than €50 per month to participate.A large percentage of patients with MBC lack the skills to engage in regular exercise as recommended by exercise guidelines for people with cancer. Patients may benefit from personalized advice and appropriate training facilities to overcome barriers. When implementing exercise interventions, attention should be given to reimbursement and the relatively low willingness-to-pay.
000285381 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000285381 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000285381 650_7 $$2Other$$aCancer survivorship
000285381 650_7 $$2Other$$aExercise
000285381 650_7 $$2Other$$aMetastatic breast cancer
000285381 650_7 $$2Other$$aPatient perspectives
000285381 650_2 $$2MeSH$$aHumans
000285381 650_2 $$2MeSH$$aMiddle Aged
000285381 650_2 $$2MeSH$$aFemale
000285381 650_2 $$2MeSH$$aBreast Neoplasms: therapy
000285381 650_2 $$2MeSH$$aCross-Sectional Studies
000285381 650_2 $$2MeSH$$aExercise
000285381 650_2 $$2MeSH$$aSurveys and Questionnaires
000285381 650_2 $$2MeSH$$aExercise Therapy
000285381 7001_ $$0P:(DE-He78)02b45d03ea9bc2c222c7aebf546803c5$$aDepenbusch, Johanna$$b1$$udkfz
000285381 7001_ $$aKampshoff, Caroline S$$b2
000285381 7001_ $$00000-0003-2574-4850$$aAaronson, Neil K$$b3
000285381 7001_ $$aHiensch, Anouk$$b4
000285381 7001_ $$00000-0001-8317-7829$$aWengström, Yvonne$$b5
000285381 7001_ $$aBackman, Malin$$b6
000285381 7001_ $$aGunasekara, Nadira$$b7
000285381 7001_ $$aClauss, Dorothea$$b8
000285381 7001_ $$aPelaez, Mireia$$b9
000285381 7001_ $$aLachowicz, Milena$$b10
000285381 7001_ $$00000-0003-0643-3790$$aMay, Anne M$$b11
000285381 7001_ $$0P:(DE-He78)a0c2037d9054be26907a05ae520d5756$$aSteindorf, Karen$$b12$$udkfz
000285381 7001_ $$00000-0002-7794-7767$$aStuiver, Martijn M$$b13
000285381 7001_ $$agroup, PERSPECTIVE survey$$b14$$eCollaboration Author
000285381 7001_ $$aArrieta, Haritz$$b15$$eContributor
000285381 7001_ $$aToribio, María Gutiérrez$$b16$$eContributor
000285381 7001_ $$aSantillan, María López$$b17$$eContributor
000285381 7001_ $$aTol, Jolien$$b18$$eContributor
000285381 7001_ $$aMalter, Wolfram$$b19$$eContributor
000285381 7001_ $$aPuppe, Julian$$b20$$eContributor
000285381 773__ $$0PERI:(DE-600)1463166-0$$a10.1007/s00520-023-08124-4$$gVol. 31, no. 12, p. 694$$n12$$p694$$tSupportive care in cancer$$v31$$x0941-4355$$y2023
000285381 909CO $$ooai:inrepo02.dkfz.de:285381$$pVDB
000285381 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)02b45d03ea9bc2c222c7aebf546803c5$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000285381 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a0c2037d9054be26907a05ae520d5756$$aDeutsches Krebsforschungszentrum$$b12$$kDKFZ
000285381 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000285381 9141_ $$y2023
000285381 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2023-10-21$$wger
000285381 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2023-10-21$$wger
000285381 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-21
000285381 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-21
000285381 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-21
000285381 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-21
000285381 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-21
000285381 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-21
000285381 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2023-10-21
000285381 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bSUPPORT CARE CANCER : 2022$$d2023-10-21
000285381 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-10-21
000285381 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-10-21
000285381 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2023-10-21
000285381 9201_ $$0I:(DE-He78)C110-20160331$$kC110$$lBewegung, Präventionsforschung und Krebs$$x0
000285381 980__ $$ajournal
000285381 980__ $$aVDB
000285381 980__ $$aI:(DE-He78)C110-20160331
000285381 980__ $$aUNRESTRICTED